7[3]White MH,Anaissie EJ,Kusne S,et al. Amphotericin B colloidal dispersion vs amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis, 1997,24:635 ～ 642
8[4]Johnson HB, Kaeffmen CA. Voriconazole: An ewtriazole antifungalagent. Clin Infect Dis,2003,36:610 ～617
9[5]Uchida K, Yokota N, Yamaguchi H. In vitro antifungal activity of posaconazole against various pathogenic fungi. Int J AntimicrobAgents ,2001,18:167 ～ 172
10[6]Arikan S,Rex JH. New agents for the treatment of systemic fungal infections - current status. Expert Opin Emerging Drugs,2002, 7:241 ～ 244
9Hariprasad SM,Mieler WF,Lin TK,et al.Voriconazole in the treatment of fungal eye infections:a review of current literature[J].Br J Ophthalmol,2008,92:871-878.
10Marangon FB,Miller D,Giaconi JA,et al.In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens[J].Am J Ophthalmol,2004,137(5):820-825.
